EMEA-001631-PIP01-14-M04
Key facts
| Invented name |
Prevymis
|
| Active substance |
Letermovir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0362/2019
|
| PIP number |
EMEA-001631-PIP01-14-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Prevention of cytomegalovirus infection
|
| Route(s) of administration |
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|